Thyrocare Technologies Limited share price
NSE: THYROCARE · ISIN INE594H01019
Key numbers
- Market cap
- ₹ 9,022 Cr
- Current price
- ₹ 566.85
- 52-week high / low
- ₹ 662 / 343
- Stock P/E
- 51.4
- Book value
- ₹ 36.8
- Dividend yield
- 2.88%
- ROCE
- 35.7%
- ROE
- 28.8%
- Debt to equity
- 0.09
- Sales growth (3 yrs)
- 16.7%
- Profit growth (3 yrs)
- 36.2%
- 1-year return
- 41.0%
About Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 187 | 193 | 196 | 224 | 240 |
| Operating profit | 58 | 58 | 58 | 75 | 77 |
| Net profit | 22 | 39 | 29 | 47 | 52 |
| EPS (₹) | - | 2.41 | 1.82 | 2.99 | 3.23 |
Peers in Diagnostics & Research
Data for information only, not investment advice. Prices end of day.